Your Immune System Is Attacking You. Here's the Genetic Reason.

Your HLA system is your immune system’s security guard. It sits on the surface of your antigen-presenting cells and shows passing T-cells what proteins are circulating in your bloodstream. Think of it as a wanted poster. Your HLA system says to your T-cells: “This is self. This is foreign. Attack the foreign, leave the self alone.”

HLA-DQ2 is one specific variant of this antigen presenter, carried by approximately 25-30% of people of European ancestry. If you carry HLA-DQ2, your immune system classifies proteins differently than people without it. The problem is that some of your own tissues share structural similarities with common food proteins (especially gluten) and pathogenic bacteria. If you carry HLA-DQ2, your immune system may flag your own intestinal lining, joints, thyroid, or neurological tissue as foreign threats because they look similar to proteins your immune system has learned to attack.

You might experience joint pain, skin rashes, chronic diarrhea, neurological symptoms, or thyroid dysfunction. You might also have celiac disease, type 1 diabetes, or rheumatoid arthritis running in your family. Your symptoms may have started after an infection or a period of high stress. You know something is wrong with your immune system, but standard blood work keeps coming back inconclusive.

Your T-cells are your immune system’s army. They hunt down pathogens and kill infected cells. But they need an off switch. CTLA4 is that off switch. It’s a checkpoint protein that sits on the surface of T-cells and, when it engages with its partner proteins on antigen-presenting cells, sends a signal that says: “Stand down. We’re done here.”

The +49A>G variant in CTLA4, carried by approximately 45% of the population, reduces the efficiency of this brake mechanism. If you carry the G allele, your T-cells are harder to turn off once they’ve been activated. They keep firing, keep producing inflammatory cytokines, and keep attacking tissues even after the threat has been eliminated. This is why autoimmune diseases have a relapsing-remitting or chronic pattern. Your immune system can’t step back.

You might experience flare-ups where your symptoms (joint pain, fatigue, neurological symptoms, skin problems) suddenly intensify, then partially resolve, then intensify again. You might notice that stress or infections trigger flares. You might have tried immune-suppressing drugs that work temporarily but lose efficacy or cause side effects. Your T-cells need a better brake, not just a heavier foot on the gas pedal.

TNF-alpha is one of your immune system’s most potent inflammatory signaling molecules. It’s released when your immune system detects a threat. It tells your body to ramp up inflammation, increase metabolic rate, and prepare for a fight. In the short term, TNF-alpha is necessary and protective. In the chronic term, sustained TNF-alpha production drives autoimmunity and tissue destruction.

The -308G>A variant in TNF, carried by approximately 30% of people with European ancestry, increases TNF-alpha production. If you carry the A allele, your baseline TNF-alpha levels are elevated, and any immune trigger (infection, stress, gut dysbiosis) pushes them even higher. This amplifies systemic inflammation, accelerates tissue damage, and drives autoimmune disease progression. It also drives neuroinflammation, contributing to brain fog and fatigue.

You might experience relentless fatigue that doesn’t respond to sleep, generalized joint and muscle pain, low-grade fever, unexplained weight loss, or brain fog. You might have elevated CRP and ESR on blood work, or you might have normal inflammation markers that mask elevated TNF-alpha. You might respond temporarily to NSAIDs or immune suppressants, but the underlying TNF-alpha problem remains unsolved.

Interleukin-6 (IL-6) is your immune system’s amplification system. When TNF-alpha or IL-1 beta signal a threat, IL-6 responds by amplifying that signal and broadcasting it system-wide. It tells your liver to produce more acute-phase proteins, your muscles to break down for energy, and your brain to increase inflammatory signaling. Like TNF-alpha, IL-6 is necessary for acute immune responses, but chronically elevated IL-6 drives autoimmunity and accelerates tissue damage.

The -174G>C variant in IL6, carried by approximately 40% of the population, increases IL-6 production. If you carry the C allele, your immune system amplifies every inflammatory signal more loudly than people with the GG genotype. This means your baseline inflammatory state is higher, and your inflammatory responses to triggers are disproportionately large. IL-6 also drives neuroinflammation, which explains why high IL-6 is linked to brain fog, mood dysfunction, and cognitive decline.

You might experience widespread inflammation symptoms: joint pain, muscle aches, fatigue, and brain fog that seem disproportionate to any identifiable trigger. Your inflammatory markers (CRP, ESR) might be chronically elevated. You might have mood symptoms, depression, or anxiety that responds partially to treatment but never fully resolves. You might notice that anti-inflammatory supplements help somewhat, but you plateau quickly.

PTPN22 is a phosphatase enzyme that fine-tunes the sensitivity threshold of your T-cells. It prevents your immune system from overreacting to minor signals. It’s one of the primary genetic mechanisms that keeps your T-cells tolerant to self-antigens and prevents autoimmunity. PTPN22 dysfunction is one of the strongest genetic risk factors for multiple autoimmune diseases.

The 1858C>T variant in PTPN22, carried by approximately 10-15% of people of European ancestry, reduces the regulatory function of this enzyme. If you carry the T allele, your T-cells have a lower threshold for activation and a weaker brake for self-tolerance. This means your immune system is more likely to attack your own tissues, and once it starts attacking, it’s harder to stop. PTPN22 variants are strongly associated with rheumatoid arthritis, type 1 diabetes, lupus, and Hashimoto’s thyroiditis.

You might have multiple autoimmune conditions running in your family. You might have already been diagnosed with one autoimmune disease and are concerned about developing others. You might notice that your symptoms are severe and progressive, not responsive to standard treatments. You might have very high autoantibody titers and aggressive immune activity.

IRF5 is a transcription factor that controls whether your dendritic cells (immune messenger cells) activate inflammatory Th17 responses or tolerant Treg responses. It’s a master switch. If IRF5 is overactive, your immune system defaults to inflammation and autoimmunity. If it’s well-regulated, your immune system defaults to tolerance. IRF5 is one of the strongest genetic determinants of whether you’ll develop lupus, rheumatoid arthritis, or systemic sclerosis.

The CGGGG repeat expansion in the IRF5 promoter region, carried by approximately 15-20% of people of European ancestry, increases IRF5 expression. If you carry the expanded repeat, your immune system defaults toward inflammatory Th17 responses and away from tolerant Treg responses. This means your baseline immune state is primed for autoimmunity. Any trigger (infection, stress, molecular mimicry) will push you toward disease activity rather than tolerance.

You might experience systemic autoimmune disease: lupus, rheumatoid arthritis, or mixed connective tissue disease. You might have photosensitivity, malar rashes, or arthritis that flares with sun exposure or stress. You might have multiple autoimmune conditions simultaneously. Your symptoms might be severe and progressive, with significant tissue damage. Standard immune suppression might work initially but eventually fail.